3500-AU-2400030. April 2024.

This medicinal product is subject to additional monitoring in Australia. This will allow quick identification of new safety information.
Healthcare professionals are asked to report any suspected adverse events at www.tga.gov.au/reporting-problems.

Please refer to the approved CAMZYOS Product Information, Boxed Warning and Black Triangle before prescribing (Click HERE).